Should I buy GSK shares at £14 after the Q3 trading update?
Yahoo Finance UK · 2 weeks ago
Open | 36.12 |
High | 36.42 |
Low | 36.10 |
Mkt. Cap | 74.04b |
P/E(TTM) | 23.26 |
Div & Yield | 1.56 & 4.31% |
Prev. Close | 36.66 |
52 Wk. Low | 34.29 |
52 Wk. High | 45.93 |
GSK plc is a British multinational pharmaceutical and biotechnology company with headquarters in London. Wikipedia
GSK (NYSE) $36.29 -0.37 (-1.01%)
Fri, Nov 8, 2024, 4:00PM EST
(GBP) | Q3 2024 | Y/Y |
---|---|---|
Revenue | 8.01B | 1.70% ▼ |
Net Income | -58M | - |
Diluted EPS | 1.29 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q4 2024 | $0.44 | - |
Q3 2024 | $1.23 | $1.29 |
Q2 2024 | $0.99 | $1.09 |
NIKKEI 225^N225 | 39,533.32+32.95 (+0.08%) |
HANG SENG^HSI | 20,438.46-289.73 (-1.40%) |
CRUDE OILCL=F | 70.36-0.02 (-0.03%) |